Diploide Genetics

We are committed to answer our client's questions quickly and accurately. Currently, we are developing next-generation medicines for people suffering from cancer, chronic and rare diseases worldwide. We provide next-generation sequencing services on next-generation sequencing platforms (NGS), including proprietary technology platforms that offer quality data at unbeatable prices for a wide variety of sequencing services and clinical applications. All quality controls are built into our procedures at every step. Offering unrivaled flexibility in diagnostic testing, and affordable genomic sequencing. Our team of medical experts has developed reliable, comprehensive and actionable genetic tests, using next-generation sequencing of the genome and individual cells by using any of our 18000+ genes. Diploide is a leading provider of genomic services and solutions with next-generation NGS with the most extensive experience in bioinformatics, and the most advanced sequencing capability in the world. We offer a wide range of next-generation sequencing services with the world's largest portfolio of genetic testing panels, enhanced with the ability to develop algorithms, chips, specific and / or specialized arrangements for medical institutions, research institutions and other partners.